Lead commercialization and pipeline strategy efforts for Seres' novel therapeutic candidates across multiple therapy areas of high unmet need. Seres Therapeutics is the leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the state of bacterial diversity and function is imbalanced.

Accountable for developing commercial strategy across the portfolio and pan-geography while building commercial capabilities for this rapidly growing Neuroscience Biotech company.

Accountable for developing global strategy and achieving worldwide revenue goals for marketed cardiovascular products, growing Eliquis to the fourth most prescribed branded drug in the US during 2017.

Directly supporting the Chief Commercial Officer for BMS and his leadership team. Accountable for actively identifying and driving strategic priorities for BMS to ensure long-term, sustainable growth and superior business performance. Core member of the Commercial Leadership Team for the company.

Expanded an enterprise-wide U.S. function to BMS' top 16 markets worldwide. Build and lead a global team with direct reports in the EU, Japan, and U.S. who ensured design, execution and optimization of integrated multichannel campaigns to ensure efficient growth of BMS' portfolio and optimize launches of BMS' immuno-oncology portfolio.

Develop and lead a new enterprise-wide function for the U.S. commercial organization to ensure design, execution, and optimization of integrated multichannel campaigns to drive top line growth of BMS' portfolio.

U.S. marketing brand lead for Abilify and lead for sales force sized at 14 district sales managers and 110 specialty representatives.

Full P&L ownership of this ~$5B neuroscience brand in the US (co-promote with Otsuka).

U.S. brand and launch lead, various urology brands (Vesicare/Avodart)

Launched large outcomes trial, several product line extensions and new indications. Marketing leadership for strategy development, crisis, and product turnaround situations.

Ranked #1 in specialty sales division for Neurology and Psychiatry products.